About the Company
We do not have any company description for Sunesis Pharmaceuticals Inc at the moment.
Please visit http://www.sunesis.com/ for more information about the company.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $SNSS News
Buy Rating for Viracta Therapeutics Backed by Upcoming Catalysts and Solid Financials
Robert Burns, an analyst from H.C. Wainwright, reiterated the Buy rating on Viracta Therapeutics (VIRX – Research Report). The associated ...
Which Is a Better Investment, Apellis Pharmaceuticals Inc or Avidity Biosciences Inc Stock?
Learn more about whether Apellis Pharmaceuticals Inc or Avidity Biosciences Inc is a better investment based on AAII's A+ ...
Ionis stock jumps as MASH drug succeeds in mid-stage trial
Ionis Pharmaceuticals (NASDAQ:IONS) shares rose in early trading on Wednesday after the company reported positive results ...
Eyenovia Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
Announced FDA approval of clobetasol propionate ophthalmic suspension 0.05% for post-operative pain and inflammation following ocular ...
Mirum Pharmaceuticals, Inc. (MIRM) Reports Q4 Loss, Tops Revenue Estimates
Mirum Pharmaceuticals, Inc. (MIRM) came out with a quarterly loss of $0.66 per share versus the Zacks Consensus Estimate of a loss of $0.34. This compares to loss of $0.99 per share a year ago. These ...
Marinus Pharmaceuticals: Q4 Earnings Snapshot
The Radnor, Pennsylvania-based company said it had a loss of 74 cents per share. The results did not meet Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment ...
Loading the latest forecasts...